Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 3 (2006), Issue 6 (June)

1. Posterior correction and fixation without anterior fusion for pseudoarthrosis with kyphotic deformity in ankylosing spondylitis.
   Spine, 31(13): E408-13. [Abstract] [Full-text]
2. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.
   Am J Med, 119(6): 503.e1-9. [Abstract] [Full-text]
3. Total ankle arthroplasty in inflammatory joint disease with use of two mobile-bearing designs.
   J Bone Joint Surg Am, 88(6): 1272-84. [Abstract] [Full-text]
4. Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis.
   Biochem Biophys Res Commun, 345(4): 1615-20. [Abstract] [Full-text]
5. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.
   Ann Rheum Dis, 65(7): 845-51. [Abstract] [Full-text]
6. Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.
   Ann Rheum Dis, 65(7): 889-94. [Abstract] [Full-text]
7. Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment.
   Ann Rheum Dis, 65(7): 924-8. [Abstract] [Full-text]
8. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register.
   Ann Rheum Dis, 65(7): 895-8. [Abstract] [Full-text]
9. Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials.
   Ann Rheum Dis, 65(7): 878-83. [Abstract] [Full-text]
10. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
    Ann Rheum Dis, 65(7): 899-904. [Abstract] [Full-text]
11. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.
    Ann Rheum Dis, 65(7): 905-9. [Abstract] [Full-text]
12. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis.
    Ann Rheum Dis, 65(7): 910-2. [Abstract] [Full-text]
13. High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery.
    Ann Rheum Dis, 65(7): 884-8. [Abstract] [Full-text]
14. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features.
    Arthritis Rheum, 55(3): 451-7. [Abstract] [Full-text]
15. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum, 55(3): 385-93. [Abstract] [Full-text]
16. Differences in disease outcomes between medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis.
    Arthritis Rheum, 55(3): 378-84. [Abstract] [Full-text]
17. Development of a tool for early referral of children and adolescents with signs and symptoms suggestive of chronic arthropathy to pediatric rheumatology centers.
    Arthritis Rheum, 55(3): 373-7. [Abstract] [Full-text]
18. Pilot study of fitness training and exercise testing in polyarticular childhood arthritis.
    Arthritis Rheum, 55(3): 364-72. [Abstract] [Full-text]
19. Rheumatology care: Involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis.
    Arthritis Rheum, 55(3): 394-401. [Abstract] [Full-text]
20. Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis.
    Arthritis Rheum, 55(3): 402-10. [Abstract] [Full-text]
21. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
    Clin Immunol, 120(1): 57-67. [Abstract] [Full-text]
22. One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial.
    Am J Phys Med Rehabil, 85(7): 559-67. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.